Form 4: Outlook Therapeutics Investor Ghiath M. Sukhtian Acquires Shares and Warrants in Private Placement

Ghiath M. Sukhtian, a director and 10% owner of Outlook Therapeutics, acquired shares and warrants through a private placement, increasing his indirect holdings in the company.

Summary

• Ghiath M. Sukhtian, a director and 10% owner of Outlook Therapeutics, indirectly acquired 2,305,714 shares of common stock and warrants to purchase 3,458,571 shares of common stock on March 18, 2024.
• The acquisition was part of a private placement transaction under a Securities Purchase Agreement (SPA) dated January 22, 2024, where shares and warrants were sold at $7.00 per share and accompanying warrant.
• These securities are held by GMS Ventures, where Ghiath M. Sukhtian holds a controlling interest.
• Effective March 14, 2024, Outlook Therapeutics implemented a 1-for-20 reverse stock split, which reduced GMS Ventures' holdings from 70,047,204 shares to 3,502,360 shares.
• Following the transaction, Ghiath M. Sukhtian indirectly beneficially owns 5,808,074 shares of common stock.

Sentiment

Score: 6

Explanation: Neutral sentiment as the document primarily reports insider transactions related to a previously announced private placement. Insider participation is generally viewed as a positive signal, but the reverse stock split could be a concern.

Positives

• Insider participation in the private placement may signal confidence in the company's future prospects.

Risks

• The document does not contain any details about risks.

Industry Context

Private placements are a common method for companies, especially in the biotech sector, to raise capital. Insider participation can be viewed positively by the market.

Related Party Transactions

• The private placement transaction involving GMS Ventures, where Ghiath M. Sukhtian holds a controlling interest, constitutes a related party transaction.

Stakeholder Impact

• The private placement provides additional capital for the company, potentially benefiting shareholders.
• The reverse stock split could negatively impact shareholders by reducing the number of outstanding shares and potentially increasing volatility.

Key Dates